Risk-adapted chemotherapy without procarbazine in treatment of children with Hodgkin lymphoma

被引：0
|
作者：
Yi-Jin Gao
Jing-Yan Tang
Ci Pan
Feng-Juan Lu
Hui-Liang Xue
Jing Chen
机构：
[1] Fudan University,Children’s Hospital, Shanghai Medical College
[2] Shanghai Jiao Tong University,Shanghai Children’s Medical Center, School of Medicine
[3] Shanghai Jiao Tong University,Shanghai Children’s Medical Center, School of Medicine
来源：
World Journal of Pediatrics | 2013年 / 9卷
关键词：
chemotherapy; children; Hodgkin lymphoma; outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：32 / 35
页数：3
相关论文
共 50 条
  • [21] RITUXIMAB IN A RISK-ADAPTED TREATMENT STRATEGY GIVES EXCELLENT THERAPEUTIC RESULTS IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA
    Della Pepa, R.
    Picardi, M.
    Giordano, C.
    Zacheo, I.
    Pugliese, N.
    Cerchione, C.
    Raimondo, M.
    Di Perna, M.
    Troncone, G.
    Ciancia, G.
    Pane, F.
    [J]. HAEMATOLOGICA, 2017, 102 : 104 - 105
  • [22] A RISK-ADAPTED, RESPONSE-BASED THERAPEUTIC REGIMEN USING A MODIFIED STANFORD V APPROACH FOR THE TREATMENT OF CHILDREN WITH HIGH RISK HODGKIN LYMPHOMA, AHOPCA LH 2004
    Castellanos, E. M.
    Metzger, M.
    Baez, L. F.
    Gamboa, Y.
    Hernandez, A. Pena
    Alabi, S.
    Luna-Fineman, S.
    Nieves, R.
    de Alarcon, P.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S147 - S147
  • [23] Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease
    Tarockoff, Meri
    Gonzalez, Teresita
    Ivanov, Stanislav
    Sandoval-Sus, Jose
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (10) : 1313 - 1326
  • [24] Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies
    Wang, Steven
    Mouliere, Florent
    Pegtel, D. Michiel
    Chamuleau, Martine E. D.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2024, 30 (07) : 660 - 672
  • [25] Mantle Cell Lymphoma: the Role of Risk-Adapted Therapy and Treatment of Relapsed Disease
    Meri Tarockoff
    Teresita Gonzalez
    Stanislav Ivanov
    Jose Sandoval-Sus
    [J]. Current Oncology Reports, 2022, 24 : 1313 - 1326
  • [26] Follicular lymphoma: are we ready for a risk-adapted approach?
    Kahl, Brad S.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 358 - 364
  • [27] Risk-adapted therapy in follicular lymphoma: Is it time to "FLEX"?
    Tobin, Joshua W. D.
    Gandhi, Maher K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1454 - 1456
  • [28] Risk-adapted chemotherapy in the adjuvant setting of breast cancer
    Möbus, V
    [J]. ONKOLOGIE, 2000, 23 (03): : 200 - 201
  • [29] Risk-adapted therapy for infantile myofibromatosis in children
    Levine, Emmanuelle
    Freneaux, Paul
    Schleiermacher, Gudrun
    Brisse, Herve
    Pannier, Stephanie
    Teissier, Natacha
    Mesples, Bettina
    Orbach, Daniel
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (01) : 115 - 120
  • [30] Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma
    Shakir, R.
    Geurts, Y.
    Ntentas, G.
    Aleman, B.
    Ramroth, J.
    John, K.
    Janus, C.
    Krol, A.
    Roesink, J.
    van den Maazen, R.
    Zijlstra, J.
    van Leeuwen, F.
    Cutter, D.
    Schaapveld, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S257 - S257
12345